{"id":"NCT02531035","sponsor":"Lexicon Pharmaceuticals","briefTitle":"A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone","officialTitle":"A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Net Clinical Benefit of Sotagliflozin as Adjunct to Insulin Therapy in Type 1 Diabetes","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-09","primaryCompletion":"2017-04","completion":"2017-04","firstPosted":"2015-08-21","resultsPosted":"2019-11-19","lastUpdate":"2020-02-12"},"enrollment":1405,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Type 1 Diabetes Mellitus (T1DM)","High Level of Sugar (Glucose) in the Blood"],"interventions":[{"type":"DRUG","name":"Sotagliflozin","otherNames":["LX4211"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Sotagliflozin 400 mg","type":"EXPERIMENTAL"}],"summary":"This Phase 3 study was designed to demonstrate the net benefit of sotagliflozin versus placebo in patients with Type 1 Diabetes (T1D).","primaryOutcome":{"measure":"Percentage of Participants With A1C <7.0% at Week 24 and No Episode of Severe Hypoglycemia and No Episode of Diabetic Ketoacidosis (DKA) After Randomization","timeFrame":"Week 24","effectByArm":[{"arm":"Placebo","deltaMin":15.2,"sd":null},{"arm":"Sotagliflozin 400 mg","deltaMin":28.6,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":4},"locations":{"siteCount":135,"countries":["United States","Argentina","Australia","Belgium","Bulgaria","Canada","Colombia","Czechia","France","Germany","Hungary","Israel","Italy","New Zealand","Poland","Slovakia","South Africa","Spain","United Kingdom"]},"refs":{"pmids":["28899222"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":23,"n":703},"commonTop":["Viral upper respiratory tract infection","Diarrhoea"]}}